Range Low Price High Price Comment
30 days $20.13 $24.38 Monday, 29th Apr 2024 SNDX stock ended at $21.28. This is 1.04% more than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 2.83% from a day low at $20.85 to a day high of $21.44.
90 days $19.60 $25.34
52 weeks $11.23 $25.34

Historical Syndax Pharmaceuticals Inc prices

Date Open High Low Close Volume
Apr 29, 2024 $21.07 $21.44 $20.85 $21.28 700 169
Apr 26, 2024 $20.59 $21.24 $20.48 $21.06 650 563
Apr 25, 2024 $20.43 $20.80 $20.13 $20.57 558 575
Apr 24, 2024 $21.02 $21.17 $20.65 $20.79 349 160
Apr 23, 2024 $21.07 $21.54 $20.91 $20.97 727 820
Apr 22, 2024 $20.99 $21.34 $20.75 $20.96 632 972
Apr 19, 2024 $20.41 $21.12 $20.37 $20.80 808 911
Apr 18, 2024 $20.65 $20.82 $20.38 $20.49 1 193 900
Apr 17, 2024 $21.55 $21.55 $20.58 $20.74 1 666 368
Apr 16, 2024 $21.46 $21.78 $21.24 $21.28 726 914
Apr 15, 2024 $21.81 $21.94 $21.48 $21.62 1 014 400
Apr 12, 2024 $22.15 $22.24 $21.52 $21.72 593 663
Apr 11, 2024 $22.24 $22.45 $21.80 $22.32 674 651
Apr 10, 2024 $22.14 $22.37 $21.81 $22.01 973 325
Apr 09, 2024 $22.86 $23.06 $22.65 $23.00 421 658
Apr 08, 2024 $23.12 $23.33 $22.59 $22.81 411 723
Apr 05, 2024 $22.45 $23.06 $22.11 $22.89 625 074
Apr 04, 2024 $23.99 $24.09 $22.57 $22.62 911 165
Apr 03, 2024 $23.01 $24.25 $22.83 $23.79 1 376 614
Apr 02, 2024 $23.19 $23.44 $22.86 $23.29 1 011 610
Apr 01, 2024 $23.67 $24.38 $22.99 $23.78 1 208 623
Mar 28, 2024 $23.18 $24.19 $22.71 $23.80 968 081
Mar 27, 2024 $21.79 $23.25 $21.69 $23.07 1 159 909
Mar 26, 2024 $22.67 $22.94 $21.42 $21.44 1 196 562
Mar 25, 2024 $22.58 $22.79 $22.40 $22.44 805 304
Click to get the best stock tips daily for free!

About Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that b... SNDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT